Successful lectin-separated bone marrow transplantation in adenosine deaminase deficiency-related severe immunodeficiency

Haematologica. 1990 Nov-Dec;75(6):546-50.

Abstract

Severe combined immunodeficiency disease (SCID) with adenosine deaminase (ADA) deficiency is a genetic autosomic recessive disorder with profound impairment of T-cell function, invariably complicated by fatal infections. The absence of ADA-enzyme and the accumulation of deoxy-ATP, with toxic effects on the T-lymphocytes is the common feature of this disease. As a consequence, lymphoid precursors failure to develop into mature T-cells, resulting in absolute lymphopenia and atrophy of the thymus. Bone marrow transplantation from an HLA-identical donor is considered the treatment of choice for this disease. We describe the case of a 1-month-old child with ADA deficiency SCID who underwent bone marrow transplantation (BMT) using paternal haploidentical, lectin-separated marrow, as a source of hemopoietic stem cells.

Publication types

  • Case Reports

MeSH terms

  • Adenosine Deaminase / deficiency*
  • Adenosine Deaminase / genetics
  • Bone Marrow Transplantation*
  • Female
  • Graft vs Host Disease
  • HLA Antigens / immunology
  • Histocompatibility
  • Humans
  • Immunologic Deficiency Syndromes / genetics
  • Immunologic Deficiency Syndromes / surgery*
  • Infant, Newborn
  • Lectins
  • Lymphocyte Depletion*
  • Plant Lectins*
  • Rosette Formation
  • Soybean Proteins*
  • T-Lymphocytes, Cytotoxic
  • Transplantation, Homologous

Substances

  • HLA Antigens
  • Lectins
  • Plant Lectins
  • Soybean Proteins
  • soybean lectin
  • Adenosine Deaminase